May 14 (SeeNews) - Serbia's largest drug maker Hemofarm's sales in euro currency fell 49% year-on-year to 16.8 million euro ($22.9 million) due to weak local demand resulting from the global financial and economic crisis, the company's German owner STADA said on Thursday.